Abstract:Background: In this study, we aimed to develop a new end-to-end learning model called Graph-Drug-Target Interaction (DTI), which integrates various types of information in the heterogeneous network data, and to explore automatic learning of the topology-maintaining representations of drugs and targets, thereby effectively contributing to the prediction of DTI. Precise predictions of DTI can guide drug discovery and development. Most machine learning algorithms integrate multiple data sources and combine them with common embedding methods. However, the relationship between the drugs and target proteins is not well reported. Although some existing studies have used heterogeneous network graphs for DTI prediction, there are many limitations in the neighborhood information between the nodes in the heterogeneous network graphs. We studied the drug-drug interaction (DDI) and DTI from DrugBank Version 3.0, protein-protein interaction (PPI) from the human protein reference database Release 9, drug structure similarity from Morgan fingerprints of radius 2 and calculated by RDKit, and protein sequence similarity from Smith-Waterman score. Methods: Our study consists of three major components. First, various drugs and target proteins were integrated, and a heterogeneous network was established based on a series of data sets. Second, the graph neural networks-inspired graph auto-encoding method was used to extract high-order structural information from the heterogeneous networks, thereby revealing the description of nodes (drugs and proteins) and their topological neighbors. Finally, potential DTI prediction was made, and the obtained samples were sent to the classifier for secondary classification. Results: The performance of Graph-DTI and all baseline methods was evaluated using the sums of the area under the precision-recall curve (AUPR) and the area under the receiver operating characteristic curve (AUC). The results indicated that Graph-DTI outperformed the baseline methods in both performance results. Conclusion: Compared with other baseline DTI prediction methods, the results showed that Graph-DTI had better prediction performance. Additionally, in this study, we effectively classified drugs corresponding to different targets and vice versa. The above findings showed that Graph-DTI provided a powerful tool for drug research, development, and repositioning. Graph- DTI can serve as a drug development and repositioning tool more effectively than previous studies that did not use heterogeneous network graph embedding.

AMGDTI: drug–target interaction prediction based on adaptive meta-graph learning in heterogeneous network

A Metagraph-Based Model for Predicting Drug-Target Interaction on Heterogeneous Network

HGDTI: predicting drug–target interaction by using information aggregation based on heterogeneous graph neural network

Graph-DTI: A New Model for Drug-target Interaction Prediction Based on Heterogenous Network Graph Embedding

A heterogeneous graph neural network with automatic discovery of effective metapaths for drug-target interaction prediction

MSH-DTI: multi-graph convolution with self-supervised embedding and heterogeneous aggregation for drug-target interaction prediction

Metapath-aggregated heterogeneous graph neural network for drug-target interaction prediction

MDGAE-DTI: Drug-Target Interactions Prediction Based on Multi-information Integration and Graph Auto-Encoder

Integrated Multi-Similarity Fusion and Heterogeneous Graph Inference for Drug-Target Interaction Prediction

Predicting Drug-Target Interactions over Heterogeneous Information Network

DTI-HETA: prediction of drug-target interactions based on GCN and GAT on heterogeneous graph

Drug-Target Interaction Prediction Using Multi-Head Self-Attention and Graph Attention Network.

Drug-Target Interaction Prediction with Graph Attention networks

MultiDTI: Drug-Target Interaction Prediction Based on Multi-Modal Representation Learning to Bridge the Gap Between New Chemical Entities and Known Heterogeneous Network.

GSL-DTI: Graph Structure Learning Network for Drug-Target Interaction Prediction

iGRLDTI: An Improved Graph Representation Learning Method for Predicting Drug-Target Interactions over Heterogeneous Biological Information Network

MGACL: Prediction Drug–Protein Interaction Based on Meta-Graph Association-Aware Contrastive Learning

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

Drug-Target Interaction Prediction Based on Heterogeneous Networks

GIAE-DTI: Predicting Drug-Target Interactions Based on Heterogeneous Network and GIN-based Graph Autoencoder

MINDG: A Drug-Target Interaction Prediction Method Based on an Integrated Learning Algorithm